Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Insider Changes in Ownership
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 8-K Event Results of operations
  8. 10-Q Report Quarterly Report
  9. 144 Insider Sale of Securities
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 144 Insider Sale of Securities
  14. 4 Insider Changes in Ownership
  15. S-3ASR Offering Registration Statement
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 4 Insider Changes in Ownership
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. 4 Insider Changes in Ownership

Page 2 of 42 · 823 filings